Buffer (1)
Launched (1)
- (1)
- (1)
- (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
ABK-001 | - | - | Chemiluminescent Substrate Solution (AE Marker) |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| GSK-2330811 | GSK-2330811 | Phase 2 Clinical | Glaxosmithkline Plc | Scleroderma, Systemic; Crohn Disease | Details |




